Pharmacological Survey of Medicinal Plants for Activity at Dopamine Receptor Subtypes. II. Screen for Binding Activity at the D1 and D2 Dopamine Receptor Subtypes

References

• Abdel-Malek S, Bastien JW, Mahler WF, Jia Q, Reinecke MG, Robinson Jr. WE, ShuYH, Zalles-Asin J (1996): Drug leads from the Kallawaya herbalists of Bolivia. 1. Background, rationale, protocol and anti-HIV activity J Ethnopharma-col 50: 157–166.
   Google Scholar
• Bastien JW (1987): Healers of the Andes; Kallawaya Herbal-ists and their Medicinal Plants. University of Utah Press, Salt Lake City.
   Google Scholar
• Bergman J, Kamien JB, Spealman RD (1990): Antagonism of cocaine self-administration by selective dopamine D1 and D2 antagonists. Behav Pharmacol 1: 355–362.
   PubMedGoogle Scholar
• Boundy VA, Luedtke RR, Molinoff PB (1993a): Development of polyclonal anti-D2 dopamine receptor antibodies to fusion proteins: Inhibition of D2 receptor-G protein inter-action. J Neurochem 60: 2181–2191.
   PubMed Web of Science ®Google Scholar
• Boundy VA, Luedtke RR, Filtz TM, Molinoff PB (1993b): Development of anti-rat D2 dopamine receptor antibodies using sequence specific peptides. Mol Pharm 43: 666–676.
   PubMed Web of Science ®Google Scholar
• Boundy VA, Luedtke RR, Galitano AL, Smith JE, Filtz TM, Kallen RG, Molinoff P (1993c): Expression and character-ization of the rat D3 dopamine receptor: Pharmacologic properties and development of antibodies. J Pharmacol Exp Thera 264: 1002–1011.
   PubMed Web of Science ®Google Scholar
• Brozoski TJ, Brown RM, Rosvoid HE, Goldman PS (1979): Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of Rhesus monkey. Science 205: 929–932.
   PubMed Web of Science ®Google Scholar
• Cai G, Gurdal H, Smith C, Wang H-Y, Friedman E (1999): Inverse agonist properties of dopamine antagonists at the D la dopamine receptor: Uncoupling of the D la dopamine receptor from Gs protein. Mol Pharmacol 56: 989–996.
   PubMed Web of Science ®Google Scholar
• Cardellina JH II, Munro MH, Fuller RW, Nanfredi KP, McKee TC, Tischler M, Bokesch HR, Gustafson KR, Beutler JA, Boyd MR (1993): A chemical screening strategy for the dereplication and prioritization of HIV-inhibitory aqueous natural product extracts. J Nat Prod 56: 1123–1129.
   PubMed Web of Science ®Google Scholar
• Cepeda C, Buchwald NA, Levine MS (1993): Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtype activated. Proc Nat Acad Sci USA 90: 9576–9580.
   PubMed Web of Science ®Google Scholar
• Chidiac P, Hebert TE, Valiquette M, Dennis M, Bouvier M (1994): Inverse agonist activity ofp-adrenergic antagonists. Mol Pharmacol 45: 490–499.
   Google Scholar
• Chio CL, Lajiness ME, Huff RH (1994a): Activation of heterologously expressed D3 dopamine receptors: Compari-son with D2 dopamine receptors. Mol Pharmacol 45: 51–60.
   PubMed Web of Science ®Google Scholar
• Chio CL, Drong RE', Riely DT, Gill GS, Slinghtom JL, Huff RM (1994b): D4 dopamine receptor-mediated signaling events determined in transfected Chinese hamster ovary cells. J Biol Chem 269: 11813–11819.
   Google Scholar
• De Lucca M, Zalles-Asin J (1992): Flora Medicinal Boliviana, Editorial Los Amigos del Libro, La Paz-Cochabamba.
   Google Scholar
• Dearry A, Gingrich JA, Falardeau P, Fremeau Jr. RT, Bates MD, Caron MG (1990): Molecular cloning and expression of the gene for a human D1 dopamine receptor. Nature 347: 72–76.
   PubMed Web of Science ®Google Scholar
• DeLean A, Stadel TM, Lefkowitz RJ (1980): A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupledp-adrenergic receptor. J Biol Chem 255: 7108–7117.
   PubMed Web of Science ®Google Scholar
• Duke JA, Ayensu ES (1985): Medicinal Plants of China, Refer-ence Publications, Inc., Algonac, Michigan.
   Google Scholar
• Filtz TM, Artymyshyn RP, Guan W, Molinoff PB (1993): Paradoxical regulation of dopamine receptor in transfected 293 cells. Mol Pharmacol 44: 371–379.
   PubMed Web of Science ®Google Scholar
• Filtz TM, Guan W, Artymyshyn RP, Pacheco M, Ford C, Molinoff PB (1994): Mechanism of up-regulation of D2L dopamine receptors by agonists and antagonists in trans-fected HEK-293 cells. J Pharmacol Exp Therapeut 271: 1574–1582.
   PubMed Web of Science ®Google Scholar
• Girault L (1987): Kallawaya, Curanderos Itenerantes de los Andes. UNICEF, ORSTOM, La Paz, 671 pp.
   Google Scholar
• Harborne JB (1984): Phytochemical Methods, A Guide to Modern Techniques for Plant Analysis. Chapman & Hall, London, UK.
   Google Scholar
• Herling S, Woods JH (1980): Chlorpromazine effects on cocaine-reinforced responding in rhesus monkeys: Recip-rocal modification of rate-altering effects of the drugs. J Pharmacol Exp Therapeut 214: 354–361.
   PubMed Web of Science ®Google Scholar
• Hu S (1980): An Enumeration of Chinese Materia Medica. The Chinese University Press, Hong Kong.
   Google Scholar
• Kapoor LD (1990): CRC Handbook of Ayurvedic Medicinal Plants. CRC Press, Boca Raton, Florida.
   Google Scholar
• Karlsson P, Smith L, Farde L, Harnryd C, Sedvall G, Wiesel F-A (1995): Lack of apparent antipsychotic effect of the D 1 -dopamine receptor antagonist SCH 39166 in acutely ill schizophrenic patients. Psychopharmacology 121: 309–313.
   PubMed Web of Science ®Google Scholar
• Kenakin T (1997) Molecular Pharmacology: A Short Course. Chapter 2. Dose-Response Curves. Blackwell Sciences, Inc. Cambridge, MA.
   Google Scholar
• Koob GF, Le HT, Creese I (1987): The D1 dopamine receptor antagonist SCH 23390 increases cocaine self-administration in the rat. Neurosci Lett 79: 315–319.
   Google Scholar
• Lachowicz JE, Sibley DR (1997): Molecular characteristics of mammalian dopamine receptors. Pharmacol & Toxicol 81: 105–113.
   PubMedGoogle Scholar
• Lange KW, Robbins TW, Marsden CD, James M, Owen AM, Paul GM (1992): L-Dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction. Psychopharmacology 107: 394–404.
   PubMed Web of Science ®Google Scholar
• Lidow MS, Goldman-Rakic PS (1994): A common action of clozapine, haloperidol and remoxipride on D1- and D2-dopamine receptors in the primate cerebral cortex. Proc Nat Acad Sci USA 91: 4353–4356.
   PubMed Web of Science ®Google Scholar
• Lidow MS, Elsworth JD, Goldman-Rakic PS (1997): Down-regulation of the D1 and D5 dopamine receptors in the primate prefrontal cortex by chronic treatment with antipsy-chotic drugs. J Pharmacol Exp Therapeu 281: 597–603.
   PubMed Web of Science ®Google Scholar
• Liu F, Wan Q, Pristupa ZB, Yu XM, Wang YT, Niznik HB (2000): Direct protein-protein coupling enables cross-talk between dopamine D5 and gamma-aminobutyric acid A receptors. Nature 403: 274–280.
   PubMed Web of Science ®Google Scholar
• Luedtke RR, Freeman RA, Boundy VA, Martin MW, Mach RH (2000): Characterization of 125I-IABN, a novel azabicy-clononane benzamide selective for D2-like dopamine receptors. Synapse 38: 438–449.
   PubMed Web of Science ®Google Scholar
• Luedtke RR, Freeman RA, Martin MW, Bastien JW, Zalles-Asin J, Reinecke MG (2002): Pharmacological survey of medi-cinal plants for activity at dopamine receptor subtypes. I. Activation of D 1-like receptor linked adenylyl cyclase. Pharm Biol 40: 315–325.
   Google Scholar
• Luedtke RR, Griffin SA, Conroy SS, Jin X, Pinto A, Se sack SR (1999): Immunoblot and immunohistochemical compari-son of murine monoclonal antibodies specific for the rat D la and D lb dopamine receptor subtypes. J Neuroim-munology 101: 170–187.
   PubMed Web of Science ®Google Scholar
• Martin MW, Scott AW, Johnston DE Jr., Griffin SA, Luedtke RR (2001): Typical antipsychotics exhibit inverse agonist activ-ity at D la dopamine receptors expressed in Sf9 cells. Eur J Pharmacol 420: 73–82.
   PubMed Web of Science ®Google Scholar
• McGonigle P, Molinoff PB (1989): Chapter 9. Quantitative aspects of drug-receptor interaction in Basic Neurochem-istry Fourth Edition (eds., Siegal G, Agranoff B, Albers RW and Molinoff P) Raven Press, New York.
   Google Scholar
• Muller U, von Cramon DY, Pollman S (1998): D 1-versus D2-receptor modulation of visuospatial working memory in humans. J Neurosci 18: 2720–2728.
   PubMed Web of Science ®Google Scholar
• Nestler EJ (1994): Hard target: Understanding dopaminergic neurotransmission. Cell 79: 923–925.
   PubMed Web of Science ®Google Scholar
• O'Dowd BF (1993): Structures of dopamine receptors. J Neurochem 60: 804–816.
   PubMed Web of Science ®Google Scholar
• O'Reilly DR, Miller L, Luckow VA (1994): Baculovirus Expres-sion Vectors: A Laboratory Manual. Oxford University Press.
   Google Scholar
• Saloman Y, Londos C, Rodbell M (1974): A highly sen-sitive adenylate cyclase assay. Anal Biochem 58: 541–548.
   Google Scholar
• Scatchard G (1949): The attractions of proteins for small mole-cules and ions. Ann NY Acad Sci 51: 662–673
   Web of Science ®Google Scholar
• Self DW, Stein L (1992): The D1 agonists SKF 82958 and SKF 77434 are self-administered by rats. Brain Res 582: 349–352.
   PubMed Web of Science ®Google Scholar
• Self DW, Barnhart WJ, Lehman DA, Nestler EJ (1996): Oppo-site modulation of cocaine-seeking behavior by D1- and D2-like dopamine receptor agonists. Science 271: 1586–1589.
   PubMed Web of Science ®Google Scholar
• Shimizu H, Daly JW, Creverling CR (1969): A radioisotopic method for measuring the formation of adenosine 3'-5'-cyclic monophosphate in incubated slices of brain. J Neurochem 16: 1609–1616.
   Web of Science ®Google Scholar
• Sokoloff P, Schwartz J-C (1995): Novel dopamine receptors half a decade later. TiPS 16: 270–275.
   PubMed Web of Science ®Google Scholar
• Su Y-F, Cubeddu LX, Perkins JP (1976): Regulation of adeno-sine 3'-5'-monophosphate content of human astrocytoma cells: Desensitization to catecholamine and prostaglandins. J Cyclic Nucleo Res 2: 257–263.
   PubMedGoogle Scholar
• Summers MD, Smith GE (1987): A Manual of Methods for Baculovirus Vectors and Insect Cell Culture Procedures. Texas Agricultural Experiment Station Bulletin No. 1555.
   Google Scholar
• Tiberi M, Caron MG (1994): High agonist-independent activity is a distinguishing feature of the dopamine D1B receptor subtype. J Biol Chem 269: 27925–27931.
   PubMed Web of Science ®Google Scholar
• Tiberi M, Jarvie KR, Silvia C, Falardeau P, Gingrich JA, Godinot M, Bertrand L, Yang-Feng T, Fremeau RT Jr., Caron MG (1991): Cloning, molecular characterization and chromosomal assignment of a gene coding a second D1 dopamine receptor subtype: Differential expression pattern in rat brain compared with the DIA receptor. Proc Nat Acad Sci USA 88: 7491–7495.
   PubMed Web of Science ®Google Scholar
• Ward AS, Li DH, Luedtke RR, Emmett-Oglesby MW (1996): Variations in the cocaine self-administration of inbred strains of rats using a progressive ratio schedule. Psy-copharm 127: 204–212.
   PubMed Web of Science ®Google Scholar
• Williams GV, Goldman-Rakic PS (1996): Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature 376: 572–575.
   Web of Science ®Google Scholar
• Woolverton WL, Johnson KM (1992): Neurobiology of cocaine abuse. TiPS 13: 193–195.
   PubMed Web of Science ®Google Scholar
• Woolverton WL, Virus RM (1989): The effects of a D1 and a D2 dopamine antagonist on behavior maintained by cocaine or food. Pharmacol Biochem Behav 32: 691–699.
   PubMed Web of Science ®Google Scholar
• Xu M, Hu XT, Cooper DC, Moratall R, Graybiel AM, White FJ, Tonegawa S (1994): Elimination of cocaine-induced hyper-activity and dopamine-mediated neurophysiological effects in dopamine D1 receptor mutant mice. Cell 79: 945–955.
   PubMed Web of Science ®Google Scholar
• Yokel RA, Wise RA (1978): Amphetamine-type reinforcement by dopamine agonists in the rat. Psychopharmacology 58: 289–297.
   PubMed Web of Science ®Google Scholar
• Zhou Q-Y, Grandy DK, Thambi L, Kushner JA, Van Tol HHM, Cone R, Pribnow D, Salon J, Bunzow JR, Civelli 0 (1990): Cloning and expression of human and rat D1 dopamine receptors. Nature 347: 76–81.
   PubMed Web of Science ®Google Scholar